AVE Science & Technology Co Ltd (688067) - Total Liabilities
Based on the latest financial reports, AVE Science & Technology Co Ltd (688067) has total liabilities worth CN¥93.09 Million CNY (≈ $13.62 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
AVE Science & Technology Co Ltd - Total Liabilities Trend (2012–2024)
This chart illustrates how AVE Science & Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is AVE Science & Technology Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
AVE Science & Technology Co Ltd Competitors by Total Liabilities
The table below lists competitors of AVE Science & Technology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Microtek International Inc
TW:2305
|
Taiwan | NT$569.67 Million |
|
Supermax Corporation Bhd
KLSE:7106
|
Malaysia | RM343.10 Million |
|
The Gold Bond Group Ltd
TA:GOLD
|
Israel | ILA249.93 Million |
|
Central Omega Resources Tbk PT
JK:DKFT
|
Indonesia | Rp1.84 Trillion |
|
Community Bancorp. Common Stock
NASDAQ:CMTV
|
USA | $1.12 Billion |
|
Old Point Financial Corporation
NASDAQ:OPOF
|
USA | $1.28 Billion |
|
St Augustine Gold and Copper Ltd
TO:SAU
|
Canada | CA$2.51 Million |
|
Chen Full International Co Ltd
TWO:8383
|
Taiwan | NT$1.84 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down AVE Science & Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AVE Science & Technology Co Ltd market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AVE Science & Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AVE Science & Technology Co Ltd (2012–2024)
The table below shows the annual total liabilities of AVE Science & Technology Co Ltd from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥65.15 Million ≈ $9.53 Million |
-2.53% |
| 2023-12-31 | CN¥66.85 Million ≈ $9.78 Million |
-10.31% |
| 2022-12-31 | CN¥74.53 Million ≈ $10.91 Million |
+6.43% |
| 2021-12-31 | CN¥70.03 Million ≈ $10.25 Million |
+17.01% |
| 2020-12-31 | CN¥59.85 Million ≈ $8.76 Million |
+33.19% |
| 2019-12-31 | CN¥44.94 Million ≈ $6.58 Million |
+11.24% |
| 2018-12-31 | CN¥40.40 Million ≈ $5.91 Million |
+18.35% |
| 2017-12-31 | CN¥34.13 Million ≈ $4.99 Million |
+1.78% |
| 2016-12-31 | CN¥33.54 Million ≈ $4.91 Million |
+76.59% |
| 2015-12-31 | CN¥18.99 Million ≈ $2.78 Million |
-16.14% |
| 2014-12-31 | CN¥22.65 Million ≈ $3.31 Million |
+13.20% |
| 2013-12-31 | CN¥20.01 Million ≈ $2.93 Million |
+6.85% |
| 2012-12-31 | CN¥18.72 Million ≈ $2.74 Million |
-- |
About AVE Science & Technology Co Ltd
AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment China, Europe, the United States, Asia, Africa, and internationally. The company offers urine formed elements analyzer and related reagents, automatic urine ana… Read more